hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes

Documenti analoghi

• hERG Potassium Channel Blockade by the HCN Channel Inhibitor Bradycardic Agent Ivabradine
  di: Melgari, Dario, et al.
  Pubblicazione: (2015)
• Molecular basis of hERG potassium channel blockade by the class Ic antiarrhythmic flecainide
  di: Melgari, Dario, et al.
  Pubblicazione: (2015)
• Modulation of hERG potassium channels by a novel small molecule activator
  di: Mitcheson, John S, et al.
  Pubblicazione: (2017)
• Electrophysiological characterization of the modified hERG(T) potassium channel used to obtain the first cryo‐EM hERG structure
  di: Zhang, Yihong, et al.
  Pubblicazione: (2020)
• Suppression of the hERG potassium channel response to premature stimulation by reduction in extracellular potassium concentration
  di: Melgari, Dario, et al.
  Pubblicazione: (2014)